FIMM Logo

Search form

  • FIMM
  • Search
  • Media
  • News
  • Suomeksi
FIMM logo

Institute for Molecular Medicine Finland
Nordic EMBL Partnership for Molecular Medicine

Building a bridge from discovery to medicine

Research

Training

poster session

Services

News

29.05.2020

The extent and impact of human genomic variation revealed by the Genome Aggregation Database, gnomAD, consortium

06.05.2020

Gene variants that protect against glaucoma identified, opening therapeutic possibilities

09.04.2020

Common disease prevention and cancer screening would benefit from genomic risk assessment

08.04.2020

Sailalitha Bollepalli’s dissertation reveals the epigenetic signature of smoking and weight-loss

06.04.2020

New version of the SynergyFinder web-tool is available

19.03.2020

A high-resolution approach to multi-dimensional clonal phenomics

16.03.2020

COVID-19 Host Genetics Initiative

13.03.2020

FIMM is taking proactive measures regarding the COVID-19 outbreak

28.02.2020

Balaguru Ravikumar’s dissertation demonstrates the value of computational frameworks on interpreting large-scale drug screening data

27.02.2020

FinnGen wel­comes Janssen and Maze Thera­peut­ics

Highlights

Gene variants that protect against glaucoma identified, opening therapeutic possibilities

An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the...

Common disease prevention and cancer screening would benefit from genomic risk assessment

A new Finnish study demonstrated the benefits of large-scale genomic information in estimating the risk of onset for cardiac diseases, diabetes and common cancers. The findings, based on the FinnGen research dataset encompassing...

FinnGen wel­comes Janssen and Maze Thera­peut­ics

FinnGen, a large-scale academic – industry, genome research collaboration in Finland coordinated by FIMM researchers now includes eleven industry partners with the addition of the Janssen Pharmaceutical Companies of Johnson...

Ma­chine learn­ing de­creases ex­per­i­men­tal costs of drug com­bin­a­tion screen­ing for trans­la­tional ap­plic­a­tions

FIMM researchers have developed an efficient machine learning model that requires only a limited set of dose-response measurements for accurate prediction of drug combination synergy in a given patient sample. The minimal-input...

ASHG TV 2019: FIMM

WebsEdge/Health presents ASHG TV 2019. Highlights and conference news from The American Society of Human Genetics (ASHG) Annual Meeting - Sharing Discoveries. Shaping our Future

Upcoming events

No upcoming events.

Latest publications

Genome-wide risk prediction of common diseases across ancestries in one million people Read full article
Evaluation of statistical approaches for association testing in noisy drug screening data Read full article
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples Read full article
High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice Read full article
Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition Read full article

Twitter feed

Tweets by FIMM_UH

EMBL

In close collaboration with:

HUS logo
FIMM

P.O. Box 20
FI-00014 University of Helsinki
FINLAND

Social Media

  • Facebook
  • Twitter
  • Vimeo
About FIMM

The mission of the Institute is to advance new fundamental understanding of the molecular, cellular and etiological basis of human diseases. This understanding will lead to improved means of diagnostics and the treatment and prevention of common health problems. Finnish clinical and epidemiological study materials will be used in the research. Learn more about FIMM.

About the website